Best Peptide Protocols
    Anti-Aging / LongevitySingle

    FOXO4-DRI 15mg: Dosage, Reconstitution & Research Protocol Guide

    Dosing ranges, reconstitution steps, administration details, cycle length, and storage guidance for FOXO4-DRI (15 mg Vial).

    Strength & Form:15 mg Vial
    FOXO4-DRI (15 mg Vial) peptide vial

    FOXO4-DRI (15 mg Vial)

    15 mg Research Peptide

    Quick Facts

    Type
    Single
    Category
    Anti-Aging / Longevity
    Vial Strength
    15 mg
    Status
    Research

    Research Purposes Only

    This information is provided for educational purposes only. This content is not intended to diagnose, treat, cure, or prevent any disease. Always consult with qualified healthcare professionals.

    Download Guide

    Save the complete FOXO4-DRI 15mg research guide as a PDF.

    Educational and research use only. Not medical advice.

    Reference

    Sources used for this guide are listed in our research database .

    What Is FOXO4-DRI 15mg?

    FOXO4-DRI 15mg Vial Overview

    FOXO4-DRI is a cell-penetrating peptide designed to selectively induce apoptosis in senescent cells by disrupting the FOXO4-p53 interaction. In aged mouse models, treatment restored fur density, renal function, and physical fitness while leaving healthy cells unaffected — a pioneering senolytic mechanism.

    FOXO4-DRI 15mg Quick Reference

    FOXO4-DRI 15mg Vial Specifications

    Peptide
    FOXO4-DRI (15 mg Vial) (NNMT inhibitor)
    Vial Content
    15 mg total peptide
    Category
    Anti-Aging / Longevity
    Administration Method
    Subcutaneous injection
    Common Use Case
    Senolytic and anti-aging research

    FOXO4-DRI 15mg Compared With Other Formats

    Details that distinguish this 15 mg format include:

    • Selective senescent cell clearance
    • Spares healthy cells
    • Pioneering senolytic mechanism

    How Does FOXO4-DRI Work?

    FOXO4-DRI Mechanism of Action

    FOXO4-DRI is a cell-penetrating peptide that disrupts the FOXO4-p53 interaction in senescent cells, allowing p53 to trigger apoptosis selectively in aged, dysfunctional cells while leaving healthy cells unaffected.

    What Are the Potential Benefits of FOXO4-DRI?

    FOXO4-DRI Research Findings and Observed Outcomes

    Findings and reported areas of study for FOXO4-DRI (15 mg Vial) include:

    • Senescent cell clearance
    • Restored tissue function in aged models
    • Selective apoptosis
    • Physical fitness restoration

    These observations are discussed for research and educational reference only and are not medical claims.

    What Do You Need to Reconstitute FOXO4-DRI 15mg?

    FOXO4-DRI 15mg Supplies for Reconstitution and Handling

    • •Insulin syringes (29–31g)
    • •Bacteriostatic water
    • •Alcohol prep pads
    • •Sharps container

    Supplies listed are for laboratory handling and research preparation purposes only.

    FOXO4-DRI 15mg Administration and Research Protocol

    FOXO4-DRI Injection Route, Frequency and Timing

    RouteSubcutaneous injection
    FrequencyEvery 3 days
    TimingConsistent timing

    FOXO4-DRI 15mg Dosage Guide

    FOXO4-DRI Dosage Ranges

    The ranges below pair the listed dose with the draw volume for this product strength.

    Low Range5 mg every 3 days
    Standard Range10 mg every 3 days
    Upper Range10 mg every 3 days (50 units)

    FOXO4-DRI 15mg Dosage to Syringe Units

    Based on reconstitution below

    Target Daily DoseDraw VolumeUnits
    5 mg0.25 mL25 units
    10 mg0.50 mL50 units

    This dosing table is unique to the 15 mg vial. Units refer to markings on a standard U-100 insulin syringe (1 unit = 0.01 mL).

    How Long Does a FOXO4-DRI 15mg Vial Last?

    FOXO4-DRI 15mg Duration by Research Dose

    At common research doses, one 15 mg vial of FOXO4-DRI typically supports:

    5 mg every 3 days~3 injections
    10 mg every 3 days~1.5 injections
    10 mg every 3 days (50 units)~1 injection

    How to Reconstitute FOXO4-DRI 15mg

    FOXO4-DRI 15mg Reconstitution With Bacteriostatic Water

    This section applies specifically to the FOXO4-DRI (15 mg Vial).

    Recommended Diluent
    Bacteriostatic water
    Diluent Volume
    0.75 mL
    Final Concentration
    20 mg/mL

    FOXO4-DRI 15mg Mixing Instructions

    1. 1Remove the vial from storage and allow it to reach room temperature (10–15 minutes).
    2. 2Wash hands thoroughly and prepare a clean workspace with all supplies.
    3. 3Using a sterile syringe, draw the appropriate volume of bacteriostatic water.
    4. 4Clean the rubber stopper of the vial with an alcohol prep pad.
    5. 5Insert the needle at a slight angle and slowly inject the diluent down the inner wall of the vial.
    6. 6Gently swirl or roll the vial until fully dissolved; the solution should appear clear and colorless.
    7. 7Label the vial with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light. Use within 2–4 weeks.

    FOXO4-DRI Stacks and Research Combinations

    FOXO4-DRI and Compatible Research Pairings

    In research settings, FOXO4-DRI (15 mg Vial) is sometimes paired with peptides such as:

    • Epitalon: Senolytic + telomere protection

    Factors That May Affect FOXO4-DRI Research Outcomes

    Supporting Factors for FOXO4-DRI Research

    Factors recorded alongside this protocol include:

    • Anti-inflammatory diet
    • Regular exercise
    • Fasting protocols may enhance senolysis

    These factors can affect how research observations are interpreted.

    FOXO4-DRI Side Effects and Safety Considerations

    FOXO4-DRI 15mg Tolerability Notes

    Very limited human data. Expensive compound.

    Some individuals report:

    • Unknown long-term profile
    • Potential flu-like symptoms from cell clearance
    • Injection site reactions

    How to Store FOXO4-DRI Before and After Reconstitution

    FOXO4-DRI 15mg Storage Requirements

    Unreconstituted
    Freeze at -20°C recommended
    Reconstituted
    Refrigerate at 2–8°C
    Post-Mix Stability
    Use within 2 weeks

    Who Should Avoid FOXO4-DRI?

    This peptide is generally not recommended for:

    • Pregnant/breastfeeding
    • Immunocompromised
    • Active infections
    • Anyone under 30 (limited senescent cell burden)

    FOXO4-DRI 15mg FAQs

    At what age should FOXO4-DRI be considered?

    Senescent cell accumulation increases significantly after age 40–50. Most research interest focuses on older populations where senescent cell burden contributes to age-related decline.

    Where to Buy FOXO4-DRI 15mg for Research

    FOXO4-DRI 15mg Purchasing and Research Supply Notes

    Before ordering FOXO4-DRI (15 mg Vial), review the product label, available testing documents, and storage instructions.

    Check the ResearchLabs listing for:

    • Available testing documents
    • Product strength and concentration
    • Storage and handling instructions
    • Current product availability

    Confirm the product strength and storage requirements before ordering. Products are for laboratory research only and are not for human consumption.

    Related Anti-Aging / Longevity Peptides

    Epithalon (10 mg Vial) productEpithalon (10 mg Vial)MOTS-c (10 mg Vial) productMOTS-c (10 mg Vial)NAD+ (500 mg Vial) productNAD+ (500 mg Vial)Pinealon (10 mg Vial) productPinealon (10 mg Vial)SS-31 (10 mg Vial) productSS-31 (10 mg Vial)SS-31 (50 mg Vial) productSS-31 (50 mg Vial)